IINN — Inspira Technologies Oxy BHN Income Statement
0.000.00%
HealthcareMicro Cap
- $15.63m
- $10.52m
Annual income statement for Inspira Technologies Oxy BHN, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | R2021 December 31st | R2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | 20-F | 20-F | 20-F | 20-F |
Standards: | IFRS | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 6.27 | 13 | 14.9 | 12.1 | 11.3 |
Operating Profit | -6.27 | -13 | -14.9 | -12.1 | -11.3 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -7.23 | -17.2 | -15 | -11.3 | -11.1 |
Provision for Income Taxes | |||||
Net Income After Taxes | -7.23 | -17.2 | -15 | -11.3 | -11.1 |
Net Income Before Extraordinary Items | |||||
Net Income | -7.23 | -17.2 | -15 | -11.3 | -11.1 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -7.23 | -17.2 | -15 | -11.3 | -11.1 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.769 | -3.14 | -1.39 | -0.933 | -0.597 |